MYC Amplification
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate VIP152 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia or Richter Syndrome (NCT04978779) | Vincerx Pharma, Inc. | 2021-12-16 |
Track MYC Amplification automatically
Every clearance here is in the API, with alerts when new ones post.